Bicara Therapeutics Statistics

Total Valuation

BCAX has a market cap or net worth of $475.01 million. The enterprise value is $13.54 million.

Market Cap	475.01M
Enterprise Value	13.54M

Important Dates

The next estimated earnings date is Saturday, August 16, 2025, before market open.

Earnings Date	Aug 16, 2025
Ex-Dividend Date	n/a

Share Statistics

BCAX has 54.54 million shares outstanding. The number of shares has increased by 4,870.87% in one year.

Current Share Class	54.54M
Shares Outstanding	54.54M
Shares Change (YoY)	+4,870.87%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	2.25%
Owned by Institutions (%)	58.04%
Float	28.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.03
P/TBV Ratio	1.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 24.62, with a Debt / Equity ratio of 0.00.

Current Ratio	24.62
Quick Ratio	24.17
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -27.26% and return on invested capital (ROIC) is -20.04%.

Return on Equity (ROE)	-27.26%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-20.04%
Return on Capital Employed (ROCE)	-23.71%
Revenue Per Employee	n/a
Profits Per Employee	-$1.68M
Employee Count	55
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BCAX has paid $258,000 in taxes.

Income Tax	258,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	12.17
200-Day Moving Average	n/a
Relative Strength Index (RSI)	35.42
Average Volume (20 Days)	1,069,634

Short Selling Information

The latest short interest is 5.08 million, so 9.32% of the outstanding shares have been sold short.

Short Interest	5.08M
Short Previous Month	6.58M
Short % of Shares Out	9.32%
Short % of Float	17.85%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-108.80M
Pretax Income	-64.84M
Net Income	-92.33M
EBITDA	-108.74M
EBIT	-108.80M
Earnings Per Share (EPS)	-$3.05

Full Income Statement

Balance Sheet

The company has $462.07 million in cash and $591,000 in debt, giving a net cash position of $461.47 million or $8.46 per share.

Cash & Cash Equivalents	462.07M
Total Debt	591,000
Net Cash	461.47M
Net Cash Per Share	$8.46
Equity (Book Value)	458.96M
Book Value Per Share	8.42
Working Capital	451.63M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$88.27 million and capital expenditures -$67,000, giving a free cash flow of -$88.34 million.

Operating Cash Flow	-88.27M
Capital Expenditures	-67,000
Free Cash Flow	-88.34M
FCF Per Share	-$1.62

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCAX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4,870.87%
Shareholder Yield	-4,870.87%
Earnings Yield	-19.44%
FCF Yield	-18.60%

Analyst Forecast

The average price target for BCAX is $29.17, which is 234.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$29.17
Price Target Difference	234.90%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1